Stay updated on Adjunctive Troriluzule in OCD Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.

Latest updates to the Adjunctive Troriluzule in OCD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision label (v3.4.2) was added, and the funding-status notice along with the prior revision label (v3.4.1) were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page version to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check28 days agoChange DetectedThe history page now includes a glossary toggle, color-coded change highlights, and legend text showing No FEAR Act Data and Revision: v3.4.0; the previous labels No FEAR Act data and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe page footer now shows a new revision entry (v3.3.4) replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page history shows Revision: v3.3.3 added and HHS Vulnerability Disclosure and Revision: v3.3.2 removed. These are administrative/site-structure updates that do not affect trial data or content.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded Revision: v3.3.2 to the page history. Removed the funding lapse notice and the previous Revision: v3.2.0.SummaryDifference0.3%

Stay in the know with updates to Adjunctive Troriluzule in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.